Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.62%
#2 Luxxcoin Luxxcoin +45.27%
#3 ResearchCoin ResearchCoin +22.78%
#4 Reactive Network Reactive Network +20.67%
#5 Orderly Network Orderly Network +16.77%
#6 Layer3 Layer3 +13.71%
#7 Bitgert Bitgert +13.08%
#8 Aria.AI Aria.AI +11.86%
#9 Useless Coin Useless Coin +9.66%
#10 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.53%
Coin of the day
Resolv wstUSR Resolv wstUSR
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Kedudukan dalam Saham #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Harga Saham
$99.32
Modal Pasaran
$48.20B
Perubahan (1 hari)
0.98%
Perubahan (1 tahun)
-32.14%
Negara
AU
Perdagangan CSL Limited (CSL)

Kategori

Healthcare
Bilangan saham terbitan bagi CSL Limited (CSL)
Bilangan saham terbitan setakat December 2025: 483.58M
Menurut laporan kewangan terkini dan harga saham CSL Limited, bilangan saham terbitan semasa ialah 483.58M. Pada akhir June 2024, syarikat mempunyai 483.01M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk CSL Limited (CSL) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 483.58M -0.06%
2025 483.88M 0.18%
2024 483.01M 0.17%
2023 482.17M 2.86%
2022 468.76M 3.05%
2021 454.87M 0.23%
2020 453.81M 0.20%
2019 452.92M 0.13%
2018 452.35M -0.65%
2017 455.33M -1.44%
2016 462.00M -2.08%
2015 471.82M -2.48%
2014 483.82M -2.97%
2013 498.61M -3.97%
2012 519.23M -3.94%
2011 540.53M -4.63%
2010 566.78M -4.78%
2009 595.24M 8.21%
2008 550.11M 0.44%
2007 547.71M 0.30%
2006 546.08M -7.12%
2005 587.97M 10.00%
2004 534.52M 11.94%
2003 477.51M 0.53%
2002 474.99M 5.89%
2001 448.57M 12.11%
2000 400.11M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 819.78%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -47.50%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M -78.72%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M -60.71%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -87.30%
NL